This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Short Report
Junpei Komagamine
National Hospital Organization Tochigi Medical Center
Corresponding Author
ORCiD: https://orcid.org/0000-0002-5899-4760
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: In Japan, the number of patients with coronavirus disease (COVID-19) has increased since the first case was confirmed in January 2020, reaching more than ten thousand cases as of April 30, 2020. Nonetheless, a true prevalence of COVID-19 in Japan remains unknown due to testing restrictions and a lack of epidemiological research for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Methods: We investigated 37 consecutive pneumonia patients hospitalized in our hospital located in Utsunomiya, Japan, from February 25 to May 16, 2020. Both nasopharyngeal swabs and sputum were obtained and sent for SARS-CoV-2 PCR testing. The percentage of positive results for SARS-CoV-2 in the screened patients was determined.
Results: None of the patients reported in this study had contact with COVID-19 patients. Of the 37 screened patients, none had positive SARS-CoV-2 test results. None were clinically diagnosed with COVID-19.
Conclusions: Our findings suggest that COVID-19 was not prevalent in this region during this period. Further studies are needed to determine an accurate number or prevalence of COVID-19 in other regions of Japan.
Keywords
COVID-19, epidemiology, pneumonia
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 12 Jun, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Infectious Diseases
Learn more about our company.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Short Report
Junpei Komagamine
National Hospital Organization Tochigi Medical Center
Corresponding Author
ORCiD: https://orcid.org/0000-0002-5899-4760
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 12 Jun, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Infectious Diseases
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: In Japan, the number of patients with coronavirus disease (COVID-19) has increased since the first case was confirmed in January 2020, reaching more than ten thousand cases as of April 30, 2020. Nonetheless, a true prevalence of COVID-19 in Japan remains unknown due to testing restrictions and a lack of epidemiological research for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Methods: We investigated 37 consecutive pneumonia patients hospitalized in our hospital located in Utsunomiya, Japan, from February 25 to May 16, 2020. Both nasopharyngeal swabs and sputum were obtained and sent for SARS-CoV-2 PCR testing. The percentage of positive results for SARS-CoV-2 in the screened patients was determined.
Results: None of the patients reported in this study had contact with COVID-19 patients. Of the 37 screened patients, none had positive SARS-CoV-2 test results. None were clinically diagnosed with COVID-19.
Conclusions: Our findings suggest that COVID-19 was not prevalent in this region during this period. Further studies are needed to determine an accurate number or prevalence of COVID-19 in other regions of Japan.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...